Thomas D. Carey - 28 Feb 2025 Form 4 Insider Report for STANDARD BIOTOOLS INC. (LAB)

Role
Director
Signature
/s/ Thomas D. Carey by Tomone Tanaka, Attorney-in-Fact
Issuer symbol
LAB
Transactions as of
28 Feb 2025
Net transactions value
+$60,000
Form type
4
Filing time
04 Mar 2025, 17:52:41 UTC
Previous filing
02 Jul 2024
Next filing
24 Jun 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LAB Common Stock Award $60,000 +56,338 +131% $1.06 99,466 28 Feb 2025 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents Restricted Stock Units ("RSUs") that vest as to 25% on the last day of the last month of each fiscal quarter of 2025, subject to the Reporting Person's continued service through the applicable vesting date.
F2 The RSUs were issued to the Reporting Person, who elected to take RSUs in lieu of $60,000 in cash compensation for certain services as a board member.